P*R*I*M*E program for menopausal women introduced by Berlex Laboratories; Program provides positive reinforcement in the menopausal experience.WAYNE, N.J.--(BUSINESS WIRE)--Sept. 8, 1995--Berlex Laboratories Inc., recognizing the need to help physicians educate patients about estrogen replacement therapy estrogen replacement therapy n. Abbr. ERT The administration of estrogen, especially in postmenopausal women, to relieve symptoms and conditions associated with estrogen deficiency, such as hot flashes and osteoporosis. (ERT ERT abbr. estrogen replacement therapy Estrogen replacement therapy (ERT) A treatment in which estrogen is used therapeutically during menopause to alleviate certain symptoms such as hot flashes. ) and promote the compliance needed for successful treatment, has introduced an innovative program called P*R*I*M*E, Positive Reinforcement positive reinforcement, n a technique used to encourage a desirable behavior. Also called positive feedback, in which the patient or subject receives encouraging and favorable communication from another person. In the Menopausal Experience. P*R*I*M*E is a multi-faceted patient-support service targeted to the users of CLIMARA(R), the only 7-day estrogen replacement patch. It is designed to provide valuable information about menopause, advances in ERT, and ways women "in the PRIME of life" can maintain a healthy active lifestyle. The prestigious New England New England, name applied to the region comprising six states of the NE United States—Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, and Connecticut. The region is thought to have been so named by Capt. Journal of Medicine's "Health News", which is an important part of the P*R*I*M*E program, is now available in the waiting rooms of ob/gyns and family physicians. The P*R*I*M*E newsletter is distributed in conjunction with "Health News" and reports on breakthrough discoveries, nutrition and other health issues, and provides resources for additional information. The newsletter will be mailed to CLIMARA patients enrolled in P*R*I*M*E. Women receive enrollment cards from their physicians or pharmacist. In addition to "Health News", P*R*I*M*E features a toll-free 24-hour information line, 1-800-ONE-WK-4-U, to answer specific questions about menopause, ERT and CLIMARA. The information line can be accessed in English, Spanish or Chinese. Information and comprehensive education of patients about menopause and ERT are important as they have been shown to raise compliance rates to as high as 92%. P*R*I*M*E will also include tools such as weekly reminder stickers to help women take advantage of the convenience of the once-a-week CLIMARA regimen. The educational program is intended to support the medical community as well by encouraging patient satisfaction and compliance with ERT and reinforcing the physician's commitment to women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. . Although estrogen replacement therapy has numerous health benefits, it is not right for everyone. For example, estrogen should not be used in women with the following conditions: known or suspected pregnancy, breast cancer, estrogen-dependent neoplasia neoplasia /neo·pla·sia/ (-pla´zhah) the formation of a neoplasm. cervical intraepithelial neoplasia , undiagnosed abnormal genital bleeding, active thrombophlebitis thrombophlebitis: see phlebitis. or thromboembolic thromboembolic pertaining to or emanating from thromboembolism. thromboembolic meningoencephalitis see hemophilosis. thromboembolic parasitism see thromboembolic colic. disorders. Women are encouraged to consult their physician on the benefits and risks of ERT. Berlex Laboratories Inc. is a research-based pharmaceutical company that develops, manufactures and markets ethical pharmaceutical products in the fields of Female Healthcare, Diagnostic Imaging, and Life-threatening and Disabling Diseases. Corporate offices are located in Wayne. CONTACT: Berlex Laboratories Inc. Wendy Neininger, 201/292-8043 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion